List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 73 studies with search of: "Abelcet"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal amphotericin B (Ambisome);   Drug: Liposomal amphotericin B (Ambisome)
2 Terminated Ambisome and Management of Culture-Negative Neutropenic Fever Unresponsive to Antibiotics
Condition: Neutropenic Fever
Interventions: Drug: Liposomal amphotericin B (AmBisome®);   Drug: Liposomal amphotericin B (AmBisome®)
3 Completed Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Liposomal Amphotericin B;   Drug: amphotericin B deoxycholate
4 Not yet recruiting To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar
Condition: Leishmaniasis, Visceral
Interventions: Drug: Amphotericin B Lipid emulsion;   Drug: Liposomal Amphotericin B
5 Completed A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
Condition: Visceral Leishmaniasis
Interventions: Drug: Amphotericin B fat emulsion in visceral leishmaniasis;   Drug: Amphotericin B fat emulsion;   Drug: Amphotericin B in fat emulsion
6 Recruiting Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Interventions: Drug: Amphotericin B Deoxycholate;   Drug: Ambisome + Miltefosine;   Drug: Ambisome and Paromomycin;   Drug: Miltefosine and Paromomycin
7 Recruiting Combination Therapy in Indian Visceral Leishmaniasis
Condition: Leishmaniasis, Visceral
Interventions: Drug: amphotericin B deoxycholate;   Drug: Liposomal Amphotericin B with Miltefosine;   Drug: Liposomal Amphotericin B and Paromomycin Sulfate;   Drug: miltefosine + Paromomycin sulfate
8 Recruiting Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
Conditions: Invasive Fungal Infections;   Hematologic Malignancies
Interventions: Drug: Posaconazole;   Drug: Amphotericin B Liquid Complex (ABLC)
9 Terminated Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for Aspergillosis
Condition: Aspergillosis
Interventions: Drug: Micafungin;   Drug: Liposomal Amphotericin B
10 Recruiting Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
Condition: Candidiasis
Interventions: Drug: micafungin;   Drug: amphotericin B deoxycholate
11 Recruiting Short Course of Miltefosine and Liposomal Amphotericin B for Kala-Azar
Condition: Visceral Leishmaniasis
Intervention: Drug: Liposomal amphotericin B and Miltefosine
12 Completed Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Amphotericin B, Lipid-based;   Drug: Amphotericin B
13 Terminated ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia
Condition: Fungal Infection
Intervention: Drug: liposomal amphotericin B (AmBisome®)
14 Completed A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
Conditions: Meningitis, Cryptococcal;   HIV Infections
Interventions: Drug: Itraconazole;   Drug: Flucytosine;   Drug: Fluconazole;   Drug: Amphotericin B
15 Completed Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
Condition: Aspergillosis
Intervention: Drug: nebulised liposomal amphotericin B
16 Completed Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia
Condition: Candidiasis
Interventions: Drug: Micafungin;   Drug: Liposomal Amphotericin B
17 Terminated Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients
Conditions: Lung Transplantation;   Lung Diseases
Intervention: Drug: Amphotericin B
18 Completed Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®)
Conditions: Lung Transplantation;   Fungal Infections
Intervention: Drug: Amphotericin B
19 Completed A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation
Conditions: Hematopoietic Stem Cell Transplantation;   Fungus Diseases
Interventions: Drug: caspofungin;   Drug: liposomal amphotericin B
20 Recruiting Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Voriconazole;   Drug: Ambisome

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services